191287-05-5

Upstream product

• 20029-52-1 4-cyclohexylbenzoic acid 
• 92863-34-8 4-cyclohexylbenzoic acid methyl ester 

Downstream Products

• 52758-46-0 3-chloro-4-cyclohexyl-benzoic acid methyl ester 
• 52758-47-1 3-chloro-4-cyclohexyl-benzyl alcohol 
• 40891-68-7 3-chloro-4-cyclohexylbenzaldehyde 
• 191287-06-6 3-amino-4-cyclohexylbenzoic acid methyl ester 

Relevant academic research and scientific papers

ANTIANGIOGENIC DRUG TO TREAT CANCER, ARTHRITIS AND RETINOPATHY

Compounds having Formula (I) or pharmaceutically acceptable salts or prodrugs thereof, are useful for treating pathological states which arise from or are exacerbated by angiogenesis. The invention also relates to pharmaceutical compositions comprising th

Antiangiogenic drug to treat cancer, arthritis and retinopathy

Compounds having Formula I or pharmaceutically acceptable salts or prodrugs thereof, are useful for treating pathological states which arise from or are exacerbated by angiogenesis. The invention also relates to pharmaceutical compositions comprising these compounds and to methods of inhibiting angiogenesis in a mammal.

The preparation of immunosuppressant SR-31747

The preparation of immunosuppressant SR-31747 is described. Attempts to install the Z-allyl amine included Lindlar partial hydrogenation and vinyl stannane methodologies. Ultimately, the Wittig olefination of aidehyde 12 with the ylide derived from β-amin